Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma

Leukemia and Lymphoma

Volumn 40, Issue 5-6, 2001, Pages 671-674

  Montefusco, E ^a   Fazi, F ^a   Cordone, I ^a   Ariola, C ^a   Nanni, M ^a   Spadea, A ^a   Aloe Spiriti, M A ^a   Fenu, S ^a   Mandelli, F ^a   Petti, M C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

AML; Chronic lymphoproliferative disease; Fludarabine and cytarabine; HU high doses; Inv (16)high dose hydroxyurea

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOSPORIN; CYTARABINE; DNA POLYMERASE; FLUDARABINE; GLYCOPROTEIN P; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; HYDROXYUREA; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERLEUKIN 2 RECEPTOR; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN; PEROXIDASE; RHODAMINE; RNA POLYMERASE; STEM CELL FACTOR RECEPTOR; TUMOR MARKER; UNINDEXED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CASE REPORT; CHRONIC DISEASE; COMORBIDITY; CYTOGENETICS; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; GENE FUSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; LEUKEMIA REMISSION; LYMPHOID TISSUE; LYMPHOPROLIFERATIVE DISEASE; MALE; MARKER GENE; MOLECULAR DYNAMICS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035050818     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097666     Document Type: Article

References (17)

1. Chronic lymphocyte leukemia associated with acute myelomonocytic leukemia
2. Concomitant myeloblastic and lymphocytic leukemia
3. Chronic lymphocytic leukemia uncovered by successful treatment of acute myeloid leukemia
4. Acute myeloid leukemia occurring in untreated chronic lymphatic leukemia
5. Simulteneous or spontaneous occurrence of lympho and myeloproliferative disorders: A report of four cases
6. Concomitant chronic lymphocytic leukemia, acute myeloid leukemia and thrombosis with protein C deficiency. Case report and review of the literature
7. Concomitant chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Complete remission of CLL achieved with high dose cytosine arabinoside
8. Cytogenetic findings in a patient presenting simultaneously with chronic lymphocytic leukemia and acute myeloid leukemia
9. Concomitant diagnosis of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). Importance of flow cytometry in the diagnosis of CLL without lymphocytosis accompanying AML
10. Concomitant chronic lymphocytic leukemia and acute myeloid leukemia with an uncommon immunophenotype
11. Simultaneous occurrence of non-Hodgkin's lymphoma and acute myelomonocytic leukemia
12. Acute myeloblastic leukemia developing in patients with mediastinal lymphoblastic lymphoma
13. Simultaneous occurrence of large B-cell non-Hodgkin's lymphoma and myelodysplastic syndrome rapidly evolving into acute myeloblastic leukemia
14. High-dose hydroxyurea (HIGH-HY) in the treatment of poor risk acute myeloid leukemia
15. Use of granulocyte colony-stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: Comparison with cytarabine without granulocyte colony-stimulating factor
16. Old and new therapies in chronic lymphocytic leukemia: Now is the time for a reassessment of therapeutic goals
17. Multidrug Resistance expression and proliferative studies in poor risk AML treated with the FLAG regimen